Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

lundbeck (schweiz) ag - memantinum - compresse rivestite con film - memantini hydrochloridum 20 mg corresp. memantinum 16.62 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto corresp. natrium max. 1.22 mg. - la malattia di alzheimer - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

lundbeck (schweiz) ag - memantinum - compresse rivestite con film - memantini hydrochloridum 10 mg corresp. memantinum 8.31 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), pro compresso obducto corresp. natrium max. 0.61 mg. - la malattia di alzheimer - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

lundbeck (schweiz) ag - memantinum - 10 mg, 15 mg, 20 mg, filmtabletten - i) 5 mg: memantini hydrochloridum 5 mg corresp. memantinum 4.15 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto corresp., natrium max. 0.3 mg. ii) 10 mg: memantini hydrochloridum 10 mg corresp. memantinum 8.31 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), pro compresso obducto corresp. natrium max. 0.61 mg. iii) 15 mg: memantini hydrochloridum 15 mg corresp. memantinum 12.46 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 0.91 mg. iv) 20 mg: memantini hydrochloridum 20 mg corresp. memantinum 16.62 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto corresp. natrium max. 1.22 mg. - la malattia di alzheimer - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

istituto biochimico italiano giovanni lorenzini s.p.a. - ciprofloxacina - ciprofloxacina

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.1 mg. - multiple sklerose - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - i) 8.8 mcg/0.2 ml: interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. ii) 22 mcg/0.5 ml: interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika